Streptococcus agalactiae (Group B streptococcus, GBS) is the major pathogen encountered in the perinatal period, although the incidence of GBS infection has recently increased among non-pregnant adults. Nevertheless, GBS infective endocarditis (IE) is uncommon and often accompanies aortic embolism. We experienced two cases of GBS IE. In Case 1, mobile vegetation of the aortic valve caused an infective cerebral aneurysm. In Case 2, the patient experienced an acute aortic embolic episode. Generally, early surgery for large mobile sites of vegetation is recommended as a class IIb therapy in the guidelines. GBS IE often exhibits a severe clinical course and specificity of vegetation. Therefore, early surgery should be considered in such cases.
A 69-yrs-old woman with anomalous origin of the right coronary artery from the opposite sinus of Valsalva (ACAOS) was diagnosed as having infective endocarditis affecting the aortic valve. Transthoracic echocardiography showed severe aortic stenosis and vegetations on the cusp of the aortic valve, which necessitated aortic valve replacement. Before the operation, computed tomography showed a right-ACAOS, with the artery running an interarterial course between the aorta and pulmonary artery. ACAOS running an interarterial course has been reported to be associated with an increased risk of ischemic cardiac events and sudden death. The patient was treated successfully by the aortic valve replacement with concurrent coronary artery bypass grafting using a saphenous vein graft for the right coronary artery.Keywords: anomalous origin of a coronary artery from the opposite sinus (ACAOS), interarterial course, infective endocarditis, coronary artery bypass grafting IntroductionCongenital coronary arterial anomalies are common, occurring in an estimated 0.3% to 1.3% of the population.1 Although most cases are clinically asymptomatic, some anomalies have been reported to be associated with an increased risk of myocardial ischemia and infarction, congestive heart failure, and/or sudden cardiac death. One of the highest-risk coronary malformations is anomalous origin of both the right and left coronary arteries from the opposite sinus of Valsalva (ACAOS),particularly in cases where the artery runs an interarterial course between the aorta and pulmonary artery.1 Anomalous origin of the left coronary artery from the opposite sinus of Valsalva (left-ACAOS) is an absolute indication for surgical intervention, whereas, the indication for surgery in patients with right-ACAOS still remains controversial. We performed aortic valve replacement and coronary artery bypass grafting in a patient with right-ACAOS presenting infective endocarditis of the aortic valve. Case ReportA 69-yrs-old woman with moderate aortic and mitral valve stenosis was referred to our out-patient clinic 2 yrs ago. She had undergone closed mitral commissurotomy 38 yrs ago and had remained in relatively A 69-yrs-old woman with anomalous origin of the right coronary artery from the opposite sinus of Valsalva (ACAOS) was diagnosed as having infective endocarditis affecting the aortic valve. Transthoracic echocardiography showed severe aortic stenosis and vegetations on the cusp of the aortic valve, which necessitated aortic valve replacement. Before the operation, computed tomography showed a right-ACAOS, with the artery running an interarterial course between the aorta and pulmonary artery. ACAOS running an interarterial course has been reported to be associated with an increased risk of ischemic cardiac events and sudden death. The patient was treated successfully by the aortic valve replacement with concurrent coronary artery bypass grafting using a saphenous vein graft for the right coronary artery.Keywords: anomalous origin of a coronary artery from the oppos...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.